These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11473346)

  • 1. Comparative rheological behavior of hyaluronan from bacterial and animal sources with cross-linked hyaluronan (hylan) in aqueous solution.
    Milas M; Rinaudo M; Roure I; Al-Assaf S; Phillips GO; Williams PA
    Biopolymers; 2001 Oct; 59(4):191-204. PubMed ID: 11473346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hydroxyl radicals on the rheological performance of hylan and hyaluronan.
    Al-Assaf S; Meadows J; Phillips GO; Williams PA; Parsons BJ
    Int J Biol Macromol; 2000 Aug; 27(5):337-48. PubMed ID: 10998492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.
    Bagga H; Burkhardt D; Sambrook P; March L
    J Rheumatol; 2006 May; 33(5):946-50. PubMed ID: 16652425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results.
    Balazs EA
    Surg Technol Int; 2004; 12():278-89. PubMed ID: 15455338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of the effects of hyaluronan and aggrecan concentration and hyaluronan size on the elasticity of hyaluronan-aggrecan solutions.
    Nishimura M; Kawata M; Yan W; Okamato A; Nishimura H; Ozaki Y; Hamada T; Kato Y
    Biorheology; 2004; 41(5):629-39. PubMed ID: 15477669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between molecular parameters of hyaluronic acid and viscoelasticity of synovia].
    Rainer F; Katzer H; Ribitsch V
    Acta Med Austriaca; 1996; 23(4):133-6. PubMed ID: 9036725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of clinical studies of the use of crosslinked hyaluronan, hylan, in the treatment of osteoarthritis.
    Adams ME
    J Rheumatol Suppl; 1993 Aug; 39():16-8. PubMed ID: 8410879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DWS microrheology of a linear polysaccharide.
    Hemar Y; Pinder DN
    Biomacromolecules; 2006 Mar; 7(3):674-6. PubMed ID: 16529397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
    Jüni P; Reichenbach S; Trelle S; Tschannen B; Wandel S; Jordi B; Züllig M; Guetg R; Häuselmann HJ; Schwarz H; Theiler R; Ziswiler HR; Dieppe PA; Villiger PM; Egger M;
    Arthritis Rheum; 2007 Nov; 56(11):3610-9. PubMed ID: 17968921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of shear and extensional viscosity measurements to assess the potential of hylan in viscosupplementation.
    al-Assaf S; Meadows J; Phillips GO; Williams PA
    Biorheology; 1996; 33(4-5):319-32. PubMed ID: 8977658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cross-linking molecular weights in a hyaluronic acid-poly(ethylene oxide) hydrogel network on its properties.
    Noh I; Kim GW; Choi YJ; Kim MS; Park Y; Lee KB; Kim IS; Hwang SJ; Tae G
    Biomed Mater; 2006 Sep; 1(3):116-23. PubMed ID: 18458391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase behavior and rheological properties of enzymatically synthesized trehalose decanoate aqueous solutions.
    Choplin L; Sadtler V; Marchal P; Sfayhi D; Ghoul M; Engasser JM
    J Colloid Interface Sci; 2006 Feb; 294(1):187-93. PubMed ID: 16125719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation.
    Pelletier JP; Martel-Pelletier J
    J Rheumatol Suppl; 1993 Aug; 39():19-24. PubMed ID: 8410880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration dependence of interstitial flow buffering by hyaluronan in synovial joints.
    Scott D; Coleman PJ; Mason RM; Levick JR
    Microvasc Res; 2000 May; 59(3):345-53. PubMed ID: 10792965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee.
    Adams ME; Lussier AJ; Peyron JG
    Drug Saf; 2000 Aug; 23(2):115-30. PubMed ID: 10945374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the pH on hyaluronan behavior in aqueous solution.
    Gatej I; Popa M; Rinaudo M
    Biomacromolecules; 2005; 6(1):61-7. PubMed ID: 15638505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison Between Rheological Properties of Intra-articular Hyaluronic Acid Preparations and Reported Human Synovial Fluid.
    Nicholls M; Manjoo A; Shaw P; Niazi F; Rosen J
    Adv Ther; 2018 Apr; 35(4):523-530. PubMed ID: 29542009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution properties of targacanthin (water-soluble part of gum tragacanth exudate from Astragalus gossypinus).
    Mohammadifar MA; Musavi SM; Kiumarsi A; Williams PA
    Int J Biol Macromol; 2006 Feb; 38(1):31-9. PubMed ID: 16469374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
    Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
    Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
    Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
    Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.